Annual EBITDA
-$55.43 M
-$20.20 M-57.34%
December 31, 2023
Summary
- As of February 7, 2025, CGON annual EBITDA is -$55.43 million, with the most recent change of -$20.20 million (-57.34%) on December 31, 2023.
- During the last 3 years, CGON annual EBITDA has fallen by -$43.05 million (-347.83%).
- CGON annual EBITDA is now -347.83% below its all-time high of -$12.38 million, reached on December 1, 2021.
Performance
CGON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$28.27 M
-$2.43 M-9.39%
September 30, 2024
Summary
- As of February 7, 2025, CGON quarterly EBITDA is -$28.27 million, with the most recent change of -$2.43 million (-9.39%) on September 30, 2024.
- Over the past year, CGON quarterly EBITDA has dropped by -$5.81 million (-25.86%).
- CGON quarterly EBITDA is now -203.66% below its all-time high of -$9.31 million, reached on December 1, 2022.
Performance
CGON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$95.94 M
-$14.24 M-17.42%
September 30, 2024
Summary
- As of February 7, 2025, CGON TTM EBITDA is -$95.94 million, with the most recent change of -$14.24 million (-17.42%) on September 30, 2024.
- Over the past year, CGON TTM EBITDA has dropped by -$27.76 million (-40.72%).
- CGON TTM EBITDA is now -930.35% below its all-time high of -$9.31 million, reached on December 1, 2022.
Performance
CGON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CGON EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.3% | -25.9% | -40.7% |
| 3 y3 years | -347.8% | -129.5% | -206.0% |
| 5 y5 years | -347.8% | -129.5% | -206.0% |
CGON EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -347.8% | at low | -203.7% | at low | -930.4% | at low |
| 5 y | 5-year | -347.8% | at low | -203.7% | at low | -930.4% | at low |
| alltime | all time | -347.8% | at low | -203.7% | at low | -930.4% | at low |
CG Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$28.27 M(+9.4%) | -$95.94 M(+17.4%) |
| Jun 2024 | - | -$25.85 M(+15.1%) | -$81.70 M(+19.8%) |
| Mar 2024 | - | -$22.46 M(+16.1%) | -$68.18 M(+23.0%) |
| Dec 2023 | -$55.43 M | -$19.35 M(+37.8%) | -$55.43 M(+22.1%) |
| Sep 2023 | - | -$14.04 M(+13.9%) | -$45.39 M(+44.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$12.32 M(+26.8%) | -$31.35 M(+64.8%) |
| Mar 2023 | - | -$9.72 M(+4.4%) | -$19.03 M(+104.4%) |
| Dec 2022 | -$35.23 M(+184.6%) | - | - |
| Dec 2022 | - | -$9.31 M | -$9.31 M |
| Dec 2021 | -$12.38 M | - | - |
FAQ
- What is CG Oncology annual EBITDA?
- What is the all time high annual EBITDA for CG Oncology?
- What is CG Oncology annual EBITDA year-on-year change?
- What is CG Oncology quarterly EBITDA?
- What is the all time high quarterly EBITDA for CG Oncology?
- What is CG Oncology quarterly EBITDA year-on-year change?
- What is CG Oncology TTM EBITDA?
- What is the all time high TTM EBITDA for CG Oncology?
- What is CG Oncology TTM EBITDA year-on-year change?
What is CG Oncology annual EBITDA?
The current annual EBITDA of CGON is -$55.43 M
What is the all time high annual EBITDA for CG Oncology?
CG Oncology all-time high annual EBITDA is -$12.38 M
What is CG Oncology annual EBITDA year-on-year change?
Over the past year, CGON annual EBITDA has changed by -$20.20 M (-57.34%)
What is CG Oncology quarterly EBITDA?
The current quarterly EBITDA of CGON is -$28.27 M
What is the all time high quarterly EBITDA for CG Oncology?
CG Oncology all-time high quarterly EBITDA is -$9.31 M
What is CG Oncology quarterly EBITDA year-on-year change?
Over the past year, CGON quarterly EBITDA has changed by -$5.81 M (-25.86%)
What is CG Oncology TTM EBITDA?
The current TTM EBITDA of CGON is -$95.94 M
What is the all time high TTM EBITDA for CG Oncology?
CG Oncology all-time high TTM EBITDA is -$9.31 M
What is CG Oncology TTM EBITDA year-on-year change?
Over the past year, CGON TTM EBITDA has changed by -$27.76 M (-40.72%)